Joseph Nabhan

Company: Vesigen Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Current Impact & Future Directions of Emerging Non-Viral CRISPR Delivery Methods 10:00 am

Outlining novel formulations being developed to target non-hepatic tissues in vivo What progress has been made in the past year to progress the safety and efficacy of these delivery methods Where are the remaining research gaps for effective tissue-targeting delivery systems?Read more

day: Day 2 AM